Insider Transactions Reported by 20 Insiders of Kronos Bio, Inc.

Location
San Mateo, CA

Insiders trading volume in the past year

Kronos Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Barbara Kosacz COO & General Counsel $1.1M 04 Jan 2024
Yasir B. Al-Wakeel Chief Financial Officer $410K 06 Jul 2023
Jorge DiMartino Chief Medical Officer & VP $373K 04 Jan 2024
Christopher Dinsmore Chief Scientific Officer $309K 04 Jan 2024
Charles Y. Lin Chief Scientific Officer $247K 15 Oct 2024
Allison Frisbee Chief Administrative Officer $216K 15 Oct 2024
Elizabeth A. Olek Sr Vp, Clinical Science $204K 21 Feb 2024
NORBERT BISCHOFBERGER Director, 10%+ Owner $0 20 Jun 2025
Arie Belldegrun Director $0 20 Jun 2025
Elena Ridloff Director $0 20 Jun 2025
Joshua A. Kazam Director $0 20 Jun 2025
Taiyin Yang Director $0 20 Jun 2025
DEBORAH KNOBELMAN President & Interim CEO $0 -$21.6K -100% 20 Jun 2025
DAVID M. TANEN Director $0 20 Jun 2025
ROGER DANSEY Director 20 Jun 2025
Marianne De Backer Director 22 Jun 2023
Roshawn Blunt Director 20 Jun 2025
SANDRA A. GARDINER Interim CFO 15 Sep 2023
Katherine V. Stultz Director 20 Jun 2025
Otello Stampacchia Director 22 Jun 2022

Recent Insider Transactions by Companies or Individuals for Kronos Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.